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MUC1、MUC4、MUC13 和 MUC15 等基因或蛋白的表达情况。 
结果：8 周龄至 16 周龄 Tabby 鼠的眼表相继出现角膜上皮缺损，角膜基质混浊，
角膜新生血管长入以及角膜血管翳形成等病变。Tabby 鼠的水性泪液分泌没有减
少，但体外泪液蒸发时间显著变短。Tabby 鼠角膜上皮细胞表面微绒毛明显减少、
缩短。Tabby 鼠的结膜杯状细胞分布密度没有变化，但其 MUC5AC 和 MUC5B
表达显著增加。Tabby 鼠角膜上皮 K10 和 SPRR1B 的表达于出生后第 4 周开始上








目的：EDA 基因编码 Ectodysplasin A (Eda)蛋白，该基因突变会导致 X 染色体连
锁外胚层发育不良综合征(X-linked anhidrotic-hypohidrotic ectodermal dysplasia, 

















方法：裂隙灯显微镜下观察 EDA 基因突变鼠（Tabby 鼠）的眼表病变。采用 ELISA
方法检测人泪液、血浆中的 Eda 浓度。用蛋白质电泳（Western blot）和/或免疫
荧光（IF）以及实时定量 PCR（qRT-PCR）检测 Eda、Eda 受体 Edar、Ki67、EGFR、
磷酸化 EGF（p-EGFR）、磷酸化 ERK1/2（p-ERK）的表达。用划痕实验检测 Eda
蛋白对人角膜上皮细胞系 HCE 细胞的迁移作用，用 CCK8 试剂检测 Eda 蛋白对
HCE 细胞的促增殖作用。 
结果：Eda 蛋白高表达于小鼠睑板腺腺泡上，人泪液中含有 Eda 蛋白，但血浆中
未检测出 Eda 蛋白。在 4-8 周龄 Tabby 鼠，角膜上皮存在缺损，角膜上皮厚度较
薄。Tabby 鼠角膜上皮的增殖细胞较少，角膜上皮损伤愈合速度较慢，在体外培
养眼球中发现 Eda 蛋白促进角膜上皮损伤愈合。Tabby 鼠角膜上皮 EGFR、
p-EGFR、p-ERK1/2 的表达水平较同龄野生型小鼠低，体外细胞培养显示 Eda 蛋
白促进 HCE 细胞 Ki67、EGFR、p-EGFR 和 p-ERK 1/2 的表达，且变化趋势与
Eda 蛋白浓度正相关。 




第三部分：外异蛋白（Eda）通过激活 SHH 信号通路调控上皮屏障 








表达水平明显低于同龄野生型小鼠。Eda 蛋白可以显著改善 Tabby 鼠的角膜上皮
屏障破坏。体外皮肤培养以及HCE细胞培养实验证实 Eda蛋白可以通过激活 Shh





































Part I. A mouse dry eye model induced by meibomian gland 
dysfunction 
Purpose: Meibomian gland dysfunction (MGD) is the most frequent cause of 
evaporative dry eye. However, its underlying pathophysiology is largely unknown. 
Our objective was to gain insight into the ocular surface change induced by MGD. 
Methods: Ocular surface changes of Ectodysplasin A（EDA） gene mutant Tabby 
mice were observed under a slit-lamp microscope and corneal epithelia defect was 
evaluated by sodium fluorescein staining. Corneal sections and eyelids were stained 
by H&E and oil red. Aqueous tear secretion was measured with phenol red thread tear 
secretion test. The corneal surface epithelial microvilli change was observed under 
scanning electron microscope (SEM). K12, K10, SPRR1B, MUC5AC, MUC1, 
MUC4，MUC13, MUC15 expression were evaluated by immunostaining and/or 
quantitative real-time PCR (qRT-PCR). 
Results: Tabby mice sequentially developed corneal epithelial defects, central corneal 
stromal edema, neovascularization, and pannus 8 to 16 weeks after birth. Aqueous tear 
secretion was normal, while ex vivo tear evaporation time were shortened. Corneal 
epithelial microvilli were less numerous whereas conjunctival goblet cell density was 
unaffected, but MUC5AC and MUC5B gene expression instead increased. 
Cytokeratin 10 and 12, SPRR1B gene expression was identified in the corneal 
epithelium of Tabby mice as early as the 4th week, which is indicative of squamous 
metaplasia.  
Conclusions: Tabby mice are a relevant model of MGD related dry eye. They may 
lead to better delineate the function of meibomian gland in maintaining ocular surface 
health, and to identify novel drug options to treat evaporative dry eye disease. 
Keywords: meibomian gland dysfunction; dry eye; Ectodysplasin A 
 
















Purpose: The EDA gene encodes ectodysplasin A (Eda) which if mutated causes 
X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) disease in humans. 
Meibomian gland absent in XLHED patients. Our objective was to identify the effect 
of Eda protein on the corneal epithelium. 
Methods: Ocular surface changes of EDA gene mutant Tabby mice were observed 
under a slit-lamp microscope. ELISA measured Eda concentration in human serum 
and tears. Eda, Eda receptor (Edar), Ki67, epidermal growth factor receptor (EGFR), 
phosphorylated EGFR (p-EGFR), and phosphorylated ERK1/2 (p-ERK) expression 
were evaluated by immunostaining and/or quantitative real-time PCR (qRT-PCR) 
and/or Western blot analysis. Eda effects on human corneal epithelial cell line (HCE) 
proliferation and migration were determined using the cell counting kit-8 (CCK8) 
assay and scratch wound healing assay, respectively.  
Results: Eda was highly expressed in meibomian glands, and it was detected in 
human tears but not serum. Corneal epithelial integrity was defective and the 
thickness was reduced in the early postnatal stage of Tabby mice. Corneal epithelial 
cell proliferation decreased and the epithelial wound healing was delayed in Tabby 
mice. Eda exposure promoted corneal epithelial wound healing during organ culture. 
EGFR, p-EGFR and p-ERK were down-regulated in Tabby mice corneal epithelium. 
Eda treatment up-regulated the expression of Ki67, EGFR, p-EGFR and p-ERK in 
HCE cells in a dose dependent manner. 
Conclusions: Eda protein can be secreted from meibomian glands and promotes 
corneal epithelial cell proliferation. Recombinant Eda may be used in the treatment of 
corneal epithelial wounding in a clinical setting. 
Keywords: Ectodysplasin A; cell proliferation; corneal epithelium 
 
Part III. Ectodysplasin A regulates epithelial barrier function though 
activating SHH signaling pathway 
Purpose: To investigate the role of Ectodysplasin A （EDA） on the skin and corneal 
epithelial barrier function. 
Methods: The ocular surface of Tabby mice was observed under slit lamp 
microscope with fluorescein staining. Corneal epithelial barrier function was 
evaluated with the permeability to carboxy fluorescein. ZO-1, Claudin-1, Gli-1 and 
















immunostaining and/or Western blot and/or quantitative real-time PCR assay. The 
cornea bacterial infection was examed by LB solid medium.  
Results: Compromise of tight junction is associated with corneal pannus and tail 
ulcer in Tabby mice raised in conventional facilities. Tight junction proteins ZO-1 
and Claudin-1 were dramatically decreased in skin and corneal epithelia of the Tabby 
mice. Topical application of recombinant Eda protein could rescue corneal epithelial 
barrier dysfunction to a large extent in Tabby mice. Moreover, the ex-vivo skin tissue 
culture and corneal epithelial cell culture indicated that the EDA regulates tight 
junction formation through activation of sonic hedgehog signaling pathway. 
Conclusions: EDA contributes to the barrier function of surface epithelial cells. Our 
findings revealed new function of EDA signal and shed new light on the 
pathophysiology and treatment of XLHED related diseases. 



















摘 要........................................................................................................... I 
Abstract ................................................................................................... IV 
第一章 绪论 .............................................................................................. 1 
1.1 睑板腺及其功能 ................................................................................................. 1 
1.2 睑板腺分泌的调节 ............................................................................................. 1 
1.3 睑板腺功能障碍 ................................................................................................. 2 
1.4 睑板腺功能障碍的诊断 ..................................................................................... 3 
1.5 睑板腺功能障碍的治疗 ..................................................................................... 3 
1.6 睑板腺功能障碍与干眼的关系 ......................................................................... 4 
1.7 研究现状 ............................................................................................................. 5 
1.8 研究意义 ............................................................................................................. 7 
第二章 睑板腺功能障碍诱导的小鼠干眼动物模型建立 ...................... 8 
2.1背景介绍 .............................................................................................................. 8 
2.2实验材料 .............................................................................................................. 9 
2.2.1主要仪器 .................................................................................................................. 9 
2.2.2 主要试剂与耗材 ................................................................................................... 10 
2.3实验方法 ............................................................................................................ 11 
2.3.1 动物饲养和繁殖 ................................................................................................... 11 
2.3.2 荧光素钠染色及评分 ........................................................................................... 11 
2.3.3 体外泪液蒸发时间测量 ....................................................................................... 11 
2.3.4 扫描电子显微镜的角膜样本制备 ....................................................................... 12 
2.3.5 过碘酸雪夫氏（PAS）染色 ................................................................................ 12 
2.3.6 H&E染色 .............................................................................................................. 12 
2.3.7 油红染色 ............................................................................................................... 13 
2.3.8 免疫荧光染色 ....................................................................................................... 13 
2.3.9 RNA的提取及反转录 .......................................................................................... 13 
2.3.10 引物设计 ............................................................................................................. 14 
2.3.11 Real Time PCR检测 ............................................................................................ 14 
2.3.12 统计方法 ............................................................................................................. 15 
2.4实验结果 ............................................................................................................ 15 
2.4.1 Tabby鼠角膜病变的发展过程 ...................................................................... 15 
2.4.2 Tabby鼠睑板腺完全缺失 .............................................................................. 18 
2.4.3 角膜荧光素钠染色结果及其评分 ................................................................. 19 
2.4.4 泪液分泌的变化及泪腺形态的观察 ............................................................. 21 
















2.4.6 Tabby鼠角膜表层微绒毛的变化 .................................................................. 24 
2.4.7 Tabby鼠的角膜上皮异常分化 ...................................................................... 24 
2.4.8 结膜杯状细胞分布密度及其功能的变化 ..................................................... 27 
2.4.9 Tabby鼠角膜和结膜的膜结合型黏蛋白表达变化 ...................................... 28 
2.5讨论 .................................................................................................................... 30 
第三章 外异蛋白（Eda）促进角膜上皮细胞增殖 ............................. 34 
3.1背景介绍 ............................................................................................................ 34 
3.2实验材料 ............................................................................................................ 35 
3.2.1主要仪器 ................................................................................................................ 35 
3.2.2 主要试剂和耗材 ................................................................................................... 36 
3.3实验方法 ............................................................................................................ 38 
3.3.1 动物饲养和繁殖 ............................................................................................. 38 
3.3.2 荧光素钠染色 ................................................................................................. 38 
3.3.3 H&E染色 ....................................................................................................... 38 
3.3.4 免疫荧光染色 ................................................................................................. 38 
3.3.5 RNA的提取及反转录 ................................................................................... 39 
3.3.6 蛋白印迹实验（Western blot） ..................................................................... 40 
3.3.7 EDU标记........................................................................................................ 42 
3.3.8 在体角膜上皮损伤修复模型建立 ................................................................. 43 
3.3.9 体外角膜上皮损伤修复模型建立 ................................................................. 43 
3.3.10 人泪液和血浆样本收集 ................................................................................. 43 
3.3.11 ELISA ............................................................................................................. 43 
3.3.12 HCE细胞培养 ................................................................................................ 44 
3.3.13 CCK8实验...................................................................................................... 44 
3.3.14 划痕实验 ......................................................................................................... 44 
3.3.15 溶液配制 ......................................................................................................... 45 
3.3.16 引物设计 ......................................................................................................... 46 
3.3.17 统计方法 ......................................................................................................... 46 
3.4实验结果 ............................................................................................................ 47 
3.4.1 睑板腺可以分泌 Eda蛋白到泪液中 ................................................................... 47 
3.4.2 Tabby鼠的角膜上皮厚度变化 ............................................................................. 49 
3.4.3 Tabby鼠角膜上皮在增殖细胞数量减少 ............................................................. 50 
3.4.4 Tabby鼠的角膜上皮损伤愈合速度异常 ............................................................. 52 
3.4.5 Eda蛋白加速角膜上皮损伤修复速度 ................................................................. 54 
3.4.6 Eda蛋白对 HCE细胞迁移的影响 ....................................................................... 55 
3.4.7 Tabby鼠的角膜上皮 EGF-EGFR信号通路检测 ................................................ 56 
3.4.8 Eda通过激活 EGF-EGFR信号通路促进 HCE细胞增殖 .................................. 58 
3.5讨论 .................................................................................................................... 59 
第四章 外异蛋白（Eda）通过激活 SHH信号通路调控上皮屏障 .. 62 
4.1背景介绍 ............................................................................................................ 62 
4.2实验材料 ............................................................................................................ 63 
4.2.1主要仪器 ................................................................................................................ 63 
4.2.2 主要试剂 ............................................................................................................... 64 
















4.3.1 动物饲养及繁殖 ................................................................................................... 65 
4.3.2 Carboxy fluorescein 渗透实验 ............................................................................. 65 
4.3.3 角膜细菌培养 ....................................................................................................... 66 
4.3.4 pcDNA3.1-EDA表达载体构建及细胞转染 ........................................................ 66 
4.3.5 上皮细胞的分离 ................................................................................................... 69 
4.3.6 皮肤组织培养 ....................................................................................................... 70 
4.3.7 免疫荧光染色 ....................................................................................................... 70 
4.3.8 蛋白印迹实验（Western blot） ........................................................................... 70 
4.3.9 荧光素钠染色及评分 ........................................................................................... 70 
4.3.10 RNA收集及 Real time PCR ............................................................................... 70 
4.3.11 引物设计 ............................................................................................................. 70 
4.3.12 统计方法 ............................................................................................................. 71 
4.4实验结果 ............................................................................................................ 71 
4.4.1 Tabby鼠的角膜和皮肤组织长期存在慢性炎症 ................................................. 71 
4.4.2 不同饲养环境下 Tabby鼠的角膜血管翳和尾巴溃疡发病率统计 ................... 73 
4.4.3 Tabby鼠角膜存在细菌感染 ................................................................................. 75 
4.4.4 Tabby鼠的角膜及皮肤上皮紧密连接蛋白 ZO-1和 Claudin-1表达下降 ......... 76 
4.4.5 Eda重组蛋白能够有效改善 Tabby鼠的角膜上皮屏障破坏 ............................. 78 
4.4.6 Eda蛋白通过激活 Shh信号通路促进 ZO-1和 Claudin-1蛋白的表达 ............ 80 
4.5讨论 .................................................................................................................... 85 
第五章 全文总结 .................................................................................... 89 
参 考 文 献 ............................................................................................ 90 
附 录......................................................................................................... 98 















Table of Contents  
 X 
Table of Contents 
 
 
Abstract in Chinese………………………………….…………………………Ⅰ 
Abstract in English………………………………….…………………………Ⅳ 
Chapter I Research Background…………….……..………………………1 
1.1 Meibomian gland and its function………………………………….……1 
1.2 Regulation of Meibomian gland secretion………………………….……1 
1.3 Meibomian gland dysfunction………………………..……………….……2 
1.4 Diognosis of Meibomian gland dysfunction…………………….……3 
1.5 Treatment of Meibomian gland dysfunction……………………….……3 
1.6 Meibomian gland dysfunction and dry eye……………………….……4 
1.7 Current research situation………………………………………….……5 
1.8 The significance of this research…………………..……………….……7 
Chapter II A mouse dry eye model induced by meibomian gland 




2.3.2 Reagents and Supplies……………….…………………………….……10 
2.3 Methods………………………………………………………….……11 
2.3.1 Animals……………………………………………………………….……11 
2.3.2 Evaluation of sodium fluorescein staining………………………….……11 
2.3.3 Ex vivo tear evaporation assay…………………………………….……11 
2.3.4 Ultra-Microstructure of corneal epithelium……………………….……12 
2.3.5 PAS staining…………………..…………………………………….……12 
2.3.6 H&E staining………………….…………………………………….……12 
2.3.7 Oil red O staining……………...………………………………….……13 
2.3.8 Immunofluorescence staining…………….……………………….……13 
2.3.9 RNA isolation and reverse transcription………………………….……13 
2.3.10 Primer design……………………………………………………….……14 
2.3.11 Quantitative real-time RT-PCR analysis……….………………….……14 













Table of Contents  
 XI 
2.4 Results………………………………………………………….…… 15 
2.4.1 Ocular surface manifestations in Tabby mice……………………….……15 
2.4.2 Absence of Meibomian gland in Tabby mice………..……………….……18 
2.4.3 Evaluation of sodium fluorescein staining…………………….……19 
2.4.4 Tear secretion and histology of lacrimal gland…………………….……21 
2.4.5 Ex vivo tear evaporation test…………………………………….……22 
2.4.6 Micorvilli change on the ocular surface………………………….……24 
2.4.7 Aberrant corneal epithelial cell differentiation……………………….……25 
2.4.8 Goblet cell distribution and functional changes…………………….……27 
2.4.9 Epithelial mucin expression profile changes………………………...……29 
2.5 Discussion………………………………………………………….……30 





3.3.2 Reagents and Supplies……………….…………………………….……36 
3.3 Methods………………………………………………………….……38 
3.3.1 Animals………………………………………..…………………….……19 
3.3.2 Sodium fluorescein staining………………….…………………….……38 
3.3.3 H&E staining………………….…………………………………….……38 
3.3.4 Immunofluorescence staining……………….…………………….……38 
3.3.5 RNA isolation and reverse transcription………………………….……39 
3.3.6 Western blot……...……………………………….………………….……40 
3.3.7 EDU labling…………………...…………………………………….……42 
3.3.8 Corneal epithelial wound healing in vivo……………………….……43 
3.3.9 Corneal epithelial wound healing ex vivo…………….……….……43 
3.3.10 Human tear and serum collection………………………………….……43 
3.3.11 ELISA…………………………………..………………………….……43 
3.3.12 HCE cell culture…………………………………………………….……44 
3.3.13 CCK8 assay………………..………….…………………………….……44 
3.3.14 Scratch wound healing assay………….………………………….……44 
3.3.15 The preparation of regents…………………..…………………….……45 













Table of Contents  
 XII 
3.3.17 Statistical analysis…………………….…………………………….……46 
3.4 Results………………………………………………………….…… 47 
3.3.1 Meibomian gland secretes Eda protein………….………………….……47 
3.3.2 The thinner corneal epithelium in Tabby mice…………………….……49 
3.3.3 Corneal epithelial cell proliferation decreased in Tabby mice…….……50 
3.3.4 Corneal epithelial wound healing delayed in Tabby mice………………52 
3.3.5 Eda promotes epithelial cell proliferation………………………….……54 
3.3.6 Effect of Eda on HCE cell migration………………………..…….……55 
3.3.7 EGF-EGFR signaling in Tabby mice corneal epithelium……………….56 
3.3.8 Eda activated EGF-EGFR signaling pathway in HCE cells…….……58 
3.5 Discussion………………………………………………………….……59 
Chapter IV Ectodysplasin A regulates epithelial barrier function 




4.3.2 Reagents and Supplies……………….…………………………….……64 
4.3 Methods………………………………………………………….……65 
4.3.1 Animals………..………………………..…………………………….……65 
4.3.2 Measurement of epithelial permeability to carboxy fluorescein…………65 
4.3.3 Corneal bacterial culture………………………………………….……65 
4.3.4 pcDNA-EDA plasmid transfection……………………………….……66 
4.3.5 The separation of epithelial cell..………………………………….……69 
4.3.6 Skin tissue explants culture…………....……..………………….……70 
4.3.7 Immunofluorescence staining……….…………………………….……70 
4.3.8 Western blotting……………...………………………………….……70 
4.3.9 Evaluation of sodium fluorescein staining………….……….……70 
4.3.10 RNA isolation and quantitative real-time RT-PCR analysis……….……70 
4.3.11 Primer design……………………………………………………….……70 
4.3.12 Statistical analysis………………………………………………….……71 
4.4 Results………………………………………………………….…… 71 
4.4.1 Inflammation in cornea and skin of Tabby mice………………….……71 
4.4.2 The incidence of corneal pannus and tail ulcer in different bleed 
environments…………………………………………………………….……73 













Table of Contents  
 XIII 
4.4.4 Declines in epithelial tight junctional protein ZO-1 and Claudin-1 
expression………………………………………………………………….……76 
4.4.5 Recombinant Eda protein topical application rescues corneal epithelial 
barrier dysfunction…………………………………..…………………….……78 
4.4.6 Eda regulates ZO-1 and Claudin-1 expression through the sonic hedgehog 
signaling pathway………………………………….………..…………….……80 
2.5 Discussion………………………………………………………….……85 




















Degree papers are in the “Xiamen University Electronic Theses and 
Dissertations Database”.  
Fulltexts are available in the following ways: 
1. If your library is a CALIS member libraries, please log on 
http://etd.calis.edu.cn/ and submit requests online, or consult the interlibrary 
loan department in your library. 
2. For users of non-CALIS member libraries, please mail to etd@xmu.edu.cn 
for delivery details. 
厦
门
大
学
博
硕
士
论
文
摘
要
库
